Playing the Long Game, Partnerships Required For Emerging Infectious Diseases

Bringing drugs and vaccines for emerging infectious diseases to the marketplace requires playing the long game and collaborations if efforts are going to be successful.

Scientist

Larry Zeitlin, president at Mapp Biopharmaceutical Inc., said he wasn't surprised when several companies – large and small – jumped into developing products to attack the Ebola virus when the outbreak struck in West Africa in 2014.

Unfortunately, some of those firms, like Chimerix Inc., Sarepta Therapeutics Inc. and Tekmira, which now goes by

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anti-infective

More from Therapeutic Category